| Lightcalls.com |
|
|
![]() |
Echinacea is a plant cluster that h...Echinacea is a plant cluster that has fascinated me since my first year in Arkansas back in 1980 When May came around, then in my unconnected unrelated home in Izard County, in the same manner came a brilliant roadside display of beautiful purple-colored primes of Echinacea flowers. That spring, I met a young botanist named Richard Davis. Richard had tend hitherward to Izard and neighboring Stone shire in northcentral Arkansas in search of a rare species of Echinacea -- the yellow-flowered Ozark endemic, Echinacea paradoxa. We construct it growing in a healthy population. It was the first time it had been accumulateed in Arkansas in 20 years. My friend, Richard, died of cancer at an early age. When I descry E. paradoxa growing, I always think of him. He sparked my continuing curiosity to learn more about this fascinating plant group What's in a name? Arkansas incline differentlyed out to be a upright place to begin learning about Echinacea, since five of the nine species in the genus Echinacea extend there. Given my botanical interests, if you read my articles, you will note that I oftentimes write of a plant "family," "genus," or "species," which are the three useful categories to understand when discussing scientific names of herbs. You can think of the plant family as analogous to a broad collection of motorized vehicles -- the "automobile family." In the automobile family, there are a number of genera (plural for genus), in the same state [i]or[/i] condition as Honda, Ford, and Chevrolet. In the genus "Honda," for example, there are several "species" delineateed by two words, the genus name, followed through the species name, such as Honda Accord or Honda Civic. To understand plant names, you can think of them in the same way as our representative automobile family. Echinacea is a genus in the aster family, within which there are nine species of Echinacea. The three species mostly commonly found in herb proceedss are: E. angustifolia, E. purpurea, and E pallida. Other species include pair federally-listed endangered species -- E tennesseensis (obviously from Tennessee) and the rare Appalachian species, E laevigata. The yellow-flowered E paradoxa (the paradox of this "purple coneflower" is that it is yellow) and E simulata (simulating E pallida) are the pair native to the Ozarks of Arkansas and Missouri. Other unusual species include E atrorubens, which swells in eastern Kansas and Oklahoma, and E sanguinea, which put forths in Louisiana and eastern Texas, with single in kind population in southwestern Arkansas. As a botanical photographer, I frequently get requests for Echinacea photos. The first question I ask the caller is: "What species are you looking for?" in the greatest degree of the time they are looking for E purpurea or E angustifolia -- the mostly commonly-used species in the American herb trade. While E purpurea, E angustifolia, and E pallida are used for the same intents there are distinct differences in their chemistry, unruffled in different plant parts, which can affect in what manner (or if) a preparation works. Therefore, when talking or writing about Echinacea, it has become important to ask the question. "Which species?" This is a significant point of consideration in herbal medicine in general. If we do not know exactly what plant material we are working with, then questions can arise across whether a product will have the desired import Plant identification is one of the chiefly significant, and often ignored, aspects of herbal medicine. It is a true important aspect of understanding Echinacea. Historical and scientific beginnings After beginning to appreciate Echinacea as a wildflower for its beauty, I became interested in delving into its herbal history. I betimes discovered that all roads l back to the writings of John Uri Lloyd (1849-1036) a name recognized according to anyone interested in the history of American medicinal plants. Lloyd became an apprentice in pharmacy at the age of 14 Eventually Lloyd and his sum of two units brothers, Curtis Gates Lloyd and Nelson Ashley Lloyd formed Lloyd Brothers Pharmacists, Inc. They manufactured 379 specific medicines," primarily derived from American medicinal plants, made for use by the agency of Eclectic physicians, who thrived in the United States from the 1850 into the 1940 and relied heavily forward American medicinal plants. Lloyd was responsible for the first pharmaceutical preparations of Echinacea introduced into the medical profession in 1895 From that time into the 1920 Echinacea (specifically preparations of E angustifolia) became the in the greatest degree widely prescribed American medicinal plant by way of physicians in the United States. John Uri Lloyd was not just a pharmacist@ he was a teacher, philanthropist, inventor, and a prolific author. He wrote more than 5000 periodical articles, six scientific treatises, and eight novels. Lloyd and his brothers also established the Lloyd Library and Museum in Cincinnati. With through the whole extent of a quarter million volumes, the Lloyd Library, to his day, is still the world's most numerous renowned, complete medicinal plant library. In 1940 John Uri Lloyd made an incredible prediction: "This [herb], which has slowly wedged its way into attention, is persistently forcing itself into conspicuity. The probabilities are that, in a time to arrive it will be ardently sought and widely used, for it is not single of the multitude that have flashed into sight, been artfully pushed, then investigated, plant wanting, and next dropped not at home of sight and out of mind." The time of which he wrote is now. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |